Cas 1027233-41-5,benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester

1027233-41-5

Post Buying Request

Basic information

Product Name: benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester
Synonyms: benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester
CAS NO:1027233-41-5
Molecular Formula:
Molecular Weight: 380.441
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester(CAS DataBase Reference)
NIST Chemistry Reference: benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester(1027233-41-5)
EPA Substance Registry System: benzoic acid 4-hydroxy-3-[3-oxo-3-(2,2,3,3-tetramethyl-cyclopropyl)-propionyl]-phenyl ester(1027233-41-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1027233-41-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1027233-41-5 Suppliers

Recommended suppliers

1027233-41-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1027233-41-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,7,2,3 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1027233-41:
(9*1)+(8*0)+(7*2)+(6*7)+(5*2)+(4*3)+(3*3)+(2*4)+(1*1)=105
105 % 10 = 5
So 1027233-41-5 is a valid CAS Registry Number.

1027233-41-5Upstream product

1027233-41-5Downstream Products

1027233-41-5Relevant academic research and scientific papers

2-Substituted 4-(thio)chromenone 6-O-sulfamates: Potent inhibitors of human steroid sulfatase

Nussbaumer, Peter,Lehr, Philipp,Billich, Andreas

, p. 4310 - 4320 (2007/10/03)

Steroid sulfatase (STS) has emerged as a highly attractive target for the therapy of a number of disorders. Starting with the known inhibitor estrone sulfamate (1) as lead compound and with the finding that steroid sulfamates containing a nonaromatic A-ri

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1027233-41-5